Atlas Trials

Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention

Clinical trial NCT06653738 · RECRUITING

Trial details

NCT number
NCT06653738
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Kidney StoneNephrolithiasisDietary Exposure
Start date
2026-07-02
Primary completion
2030-09-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.